Lars Örning

2.9k total citations · 1 hit paper
50 papers, 2.2k citations indexed

About

Lars Örning is a scholar working on Physiology, Molecular Biology and Hematology. According to data from OpenAlex, Lars Örning has authored 50 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 15 papers in Molecular Biology and 15 papers in Hematology. Recurrent topics in Lars Örning's work include Asthma and respiratory diseases (18 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers) and Hemophilia Treatment and Research (10 papers). Lars Örning is often cited by papers focused on Asthma and respiratory diseases (18 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers) and Hemophilia Treatment and Research (10 papers). Lars Örning collaborates with scholars based in United States, Sweden and Norway. Lars Örning's co-authors include Sven Hammarström, F.A. Fitzpatrick, Bengt Samuelsson, Kjell S. Sakaríassen, Sven Hammarström, Gwen G. Krivi, Vincent T. Turitto, James K. Gierse, L. Kaijser and Kerstin Bernström and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Lars Örning

50 papers receiving 2.1k citations

Hit Papers

Leukotriene D: a slow reacting substance from rat basophi... 1980 2026 1995 2010 1980 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Örning United States 25 810 544 460 351 282 50 2.2k
Michael Shipley United Kingdom 14 723 0.9× 409 0.8× 295 0.6× 266 0.8× 63 0.2× 24 2.3k
M Boisseau France 30 546 0.7× 771 1.4× 160 0.3× 458 1.3× 562 2.0× 136 3.5k
A. J. G. Swaak Netherlands 25 340 0.4× 463 0.9× 656 1.4× 130 0.4× 628 2.2× 65 2.5k
István Karádi Hungary 37 351 0.4× 904 1.7× 374 0.8× 175 0.5× 505 1.8× 140 3.8k
Naoto Yamaguchi Japan 31 285 0.4× 976 1.8× 149 0.3× 329 0.9× 143 0.5× 105 2.5k
Bruno Fouqueray France 28 291 0.4× 608 1.1× 113 0.2× 468 1.3× 352 1.2× 78 3.1k
Michael Samoszuk United States 23 537 0.7× 462 0.8× 418 0.9× 285 0.8× 52 0.2× 70 2.1k
Takuji Naruse Japan 25 121 0.1× 639 1.2× 272 0.6× 224 0.6× 404 1.4× 125 2.0k
Stefania Momi Italy 23 415 0.5× 310 0.6× 90 0.2× 249 0.7× 610 2.2× 40 1.9k
Maurice M. A. L. Pelsers Netherlands 26 407 0.5× 949 1.7× 157 0.3× 176 0.5× 104 0.4× 43 2.7k

Countries citing papers authored by Lars Örning

Since Specialization
Citations

This map shows the geographic impact of Lars Örning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Örning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Örning more than expected).

Fields of papers citing papers by Lars Örning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Örning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Örning. The network helps show where Lars Örning may publish in the future.

Co-authorship network of co-authors of Lars Örning

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Örning. A scholar is included among the top collaborators of Lars Örning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Örning. Lars Örning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Örning, Lars, A. Patricia Campbell, Jeff Brady, et al.. (2006). Characterization of a monoclonal antibody with specificity for holo-transcobalamin. Nutrition & Metabolism. 3(1). 3–3. 24 indexed citations
2.
Fedosov, Sergey N., Lars Örning, Edward V. Quadros, et al.. (2005). Mapping the functional domains of human transcobalamin using monoclonal antibodies. FEBS Journal. 272(15). 3887–3898. 14 indexed citations
3.
Namour, Farès, Anne‐Catherine Helfer, Edward V. Quadros, et al.. (2003). Transcobalamin deficiency due to activation of an intra exonic cryptic splice site. British Journal of Haematology. 123(5). 915–920. 21 indexed citations
4.
Refsum, Helga, Chittaranjan S. Yajnik, Milind Gadkari, et al.. (2001). Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. American Journal of Clinical Nutrition. 74(2). 233–241. 310 indexed citations
6.
Örning, Lars & F.A. Fitzpatrick. (1999). Modification of Leukotriene A4 Hydrolase/Aminopeptidase by Sulfhydryl-Blocking Reagents: Differential Effects on Dual Enzyme Activities by Methyl-Methane Thiosulfonate. Archives of Biochemistry and Biophysics. 368(1). 131–138. 2 indexed citations
7.
Bergseth, Steinar, et al.. (1998). Expression of the second epidermal growth factor-like domain of human factor VII in Escherichia coli. Journal of Biotechnology. 66(2-3). 203–210. 4 indexed citations
8.
Örning, Lars, Ross W. Stephens, Lizette B. Petersen, et al.. (1997). A PEPTIDE SEQUENCE FROM THE EGF-2 LIKE DOMAIN OF FVII INHIBITS TF-DEPENDENT FX ACTIVATION.. Thrombosis Research. 86(1). 57–67. 10 indexed citations
10.
Stephens, Ross W., Lars Örning, Helge Stormorken, et al.. (1996). Characterisation of cell-surface procoagulant activities using a microcarrier model. Thrombosis Research. 84(6). 453–461. 6 indexed citations
11.
Fitzpatrick, F.A., Robert A. Lepley, Lars Örning, & Kevin L. Duffin. (1994). Effects of Leukotriene A4 on Neutrophil Activationa. Annals of the New York Academy of Sciences. 714(1). 64–74. 6 indexed citations
12.
Fitzpatrick, F.A., Robert A. Lepley, Lars Örning, & Kevin L. Duffin. (1994). Suicide Inactivation of Leukotriene A4 Hydrolase/Aminopeptidasea. Annals of the New York Academy of Sciences. 744(1). 31–38. 7 indexed citations
13.
Örning, Lars & F.A. Fitzpatrick. (1992). Albumins activate peptide hydrolysis by the bifunctional enzyme LTA4 hydrolase/aminopeptidase. Biochemistry. 31(17). 4218–4223. 32 indexed citations
14.
Juhn, Steven K., Lars Örning, Sven Hammarström, Per Hedqvist, & Jan Wersäll. (1989). Distribution and metabolism of leukotriene C4 after cisternal injection in guinea pigs. Prostaglandins Leukotrienes and Essential Fatty Acids. 36(3). 135–141. 2 indexed citations
15.
Örning, Lars, et al.. (1988). In vitro formation of ω-oxidized metabolites of leukotriene C4 in the rat. Prostaglandins. 35(4). 493–501. 10 indexed citations
16.
Hammarström, Sven, et al.. (1988). Metabolism of Cysteinyl Leukotrienes to Novel Polar Metabolites in the Rat and Endogenous Formation of Leukotriene D4 during Systemic Anaphylaxis in the Guinea Piga. Annals of the New York Academy of Sciences. 524(1). 43–67. 6 indexed citations
17.
Örning, Lars. (1987). ω‐Oxidation of cysteine‐containing leukotrienes by rat‐liver microsomes. European Journal of Biochemistry. 170(1-2). 77–85. 42 indexed citations
18.
Örning, Lars, Elisabeth Norin, Bengt E. Gustafsson, & Sven Hammarström. (1986). In vivo metabolism of leukotriene C4 in germ-free and conventional rats. Fecal excretion of N-acetylleukotriene E4.. Journal of Biological Chemistry. 261(2). 766–771. 47 indexed citations
19.
Bernström, Kerstin, Lars Örning, & Sven Hammarström. (1982). [5] γ-Glutamyl transpeptidase, a leukotriene metabolizing enzyme. Methods in enzymology on CD-ROM/Methods in enzymology. 38–45. 19 indexed citations
20.
Hammarström, Sven, Kerstin Bernström, Lars Örning, et al.. (1981). Rapid metabolism of Leukotriene C3 in the monkey,. Biochemical and Biophysical Research Communications. 101(4). 1109–1115. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026